AMO Introduces blink-TM- Contacts - the Next Generation of Lubricating Eye Drops for Contact Lens Wearers - at the American Optometric Association's 107th Annual Congress.

ORLANDO, Fla. -- Advanced Medical Optics, Inc. (AMO) (NYSE:AVO), a global leader in ophthalmic surgical devices and eye care products, announced today from the American Optometric Association's 107th Annual Congress, the launch of blink(TM) Contacts rewetting drops to the professional market. Available this summer, blink(TM) Contacts is a new generation of lubricant eye drops for contact lens wearers that provides relief as natural as blinking.

blink(TM) Contacts is an advanced lubricating formula designed to refresh contact lens wearers' eyes just like natural tears, and to provide longer-lasting moisture and comfort. In a clinical trial, patients reported an increase in the amount of time they could wear their contacts compared to previous contact lens drops. The study showed 86 percent indicating improved lens-wearing comfort with blink(TM) Contacts, and 73 percent reporting improved vision quality.

blink(TM) Contacts contains the unique ingredient hyaluronate (HA), a naturally occurring lubricant found throughout the body, including in the eyes. HA is also a key ingredient in ophthalmic viscoelastic devices that AMO is expected to acquire as part of its acquisition of the Pfizer ophthalmic surgical business.

The HA in blink(TM) Contacts contains unique viscoelastic properties that mimic the behavior of natural tears, providing high viscosity before and after a blink to keep the contact lens and eye moisturized longer without blurring vision. blink(TM) Contacts contains the highest available concentration of HA, prolonging tear break-up time which produces longer-lasting moisture to keep eyes refreshed and comfortable. blink(TM) Contacts can be used with both soft and gas permeable contact lenses.

In addition to HA, blink(TM) Contacts Lubricant Eye Drops contain:

--OcuPure(TM) - a peroxide-free, non-sensitizing, preservative that dissipates when exposed to light, transforming into the natural tear components of water and sodium chloride.

--Electrolytes - fortified with five essential electrolytes found in natural tears - calcium, sodium, potassium, chloride and magnesium - to help maintain cell integrity for healthy lens wear.

"We developed blink(TM) Contacts in response to an increasing demand from contact lens wearers for a product that would make their lenses more comfortable and alleviate dryness-related discomfort," said Richard Scott, vice president of marketing for AMO's global eye care business. "Blinking is the body's natural way of replenishing the tear film. blink(TM) Contacts provides this natural relief and longer, more comfortable lens wear while also supporting a healthy lens-wearing experience, and it does it in the blink of an eye."

blink(TM) Contacts is available in the eye care section at mass retail, grocery and drug stores throughout the U.S. blink(TM) Contacts is also available in Europe and Asia Pacific, as well as Canada under the name blink(TM) CL.

For more information, please visit www.amoeyecare.com.

About Advanced Medical Optics

Advanced Medical Optics, Inc. (AMO) is a global leader in the development, manufacturing and marketing of eye care and ophthalmic surgical products. The company focuses on developing a broad suite of innovative technologies and devices to address a wide range of eye disorders. Products in the ophthalmic surgical line include foldable intraocular lenses, phacoemulsification systems, viscoelastics and related products used in cataract surgery, and microkeratomes used in LASIK procedures for refractive error correction. AMO owns or has the rights to such well-known ophthalmic surgical product brands as Phacoflex(R), Clariflex(R), Array(R) and Sensar(R) foldable intraocular lenses, the Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(TM) technology and the Amadeus(TM) microkeratome. Products in the eye care line include contact lens disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the well-known contact lens care product brands the company possesses are COMPLETE(R) MoisturePLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(R) and blink(TM) branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd.

Advanced Medical Optics, Inc. is based in Santa Ana, California, and employs approximately 2,300 worldwide. The company has operations in about 20 countries and markets products in approximately 60 countries. For more information, visit the company's web site at www.amo-inc.com.

Forward-Looking Statements

This press release contains forward-looking statements about AMO, product benefits and our planned acquisition of Pfizer's ophthalmic surgical business. Any statements in this press release that refer to AMO's anticipated distribution of the product, such as Mr. Scott's statements, and AMO's estimated or anticipated future results are forward-looking statements. All forward-looking statements in this press release reflect AMO's current analysis of existing trends and information and represent AMO's judgment only as of the date of this press release. Actual results may differ from current expectations based on a number of factors affecting AMO's business, including but not limited to unpredictable competitive, regulatory and market conditions; the performance acceptance of new products; AMO's ability to produce an adequate supply of products; the execution of strategic initiatives; and the uncertainties associated with intellectual property protection for these products. In addition, consummation of the Pfizer acquisition is subject to certain closing conditions. Therefore, the reader is cautioned not to rely on these forward-looking statements. AMO disclaims any intent or obligation to update these forward-looking statements.

Additional information concerning these and other risk factors may be found in previous financial press releases issued by AMO. AMO's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Certain Factors and Trends Affecting AMO and its Businesses" in AMO's 2003 Form 10-K and Form 10-Q filed May 2004 also include information concerning these and other risk factors. Copies of press releases and additional information about AMO are available on the World Wide Web at www.amo-inc.com, or you can contact the AMO Investor Relations Department by calling [phone].